Physician
Pathway Healthcare- Mississippi LLC
Pathway Healthcare- Mississippi LLC was paid $2.61M by Medicaid between Jan 2018 and Dec 2024, across 26 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 41% of everything it billed.
33Billing provider infoPATHWAY HEALTHCARE- MISSISSIPPI LLC
VICKSBURG, MS 39180
VICKSBURG, MS 39180
33aNPI1013425503assigned 01/18/2018
33bProvider typeAddiction Medicine (Family Medicine) Physician
28Total paid$2.61M
24GClaims86,164
24DCodes billed26
24AFirst – last monthJan 2018 – Dec 2024
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 5,434 | $72K | |
| 2019 | 8,718 | $129K | |
| 2020 | 20,623 | $378K | |
| 2021 | 17,743 | $675K | |
| 2022 | 16,762 | $712K | |
| 2023 | 9,433 | $374K | |
| 2024incomplete | 7,451 | $269K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 41% | 25,628 | 15,983 | $1.07M |
| G2087 | Office-based treatment for opioid use disorder, including care coordination, individual therapy and group therapy and counseling; at least 60 minutes in a subsequent calendar month | 27% | 4,759 | 4,241 | $704K |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed | 9.5% | 4,018 | 3,041 | $249K |
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed | 6.7% | 2,245 | 1,531 | $175K |
| 80305 | 4.8% | 26,360 | 16,376 | $126K | |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | 2.8% | 1,104 | 820 | $73K |
| 99406 | 1.8% | 10,462 | 6,537 | $47K | |
| 90832 | Psychotherapy session, about 30 minutesPsychotherapy, 30 minutes with patient | 1.7% | 1,124 | 922 | $44K |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed | 1.6% | 615 | 343 | $42K |
| 90834 | Psychotherapy session, about 45 minutesPsychotherapy, 45 minutes with patient | <1% | 223 | 195 | $15K |
| 99484 | <1% | 3,319 | 2,909 | $11K | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 162 | 141 | $10K |
14 more codes
| 90837 | Psychotherapy session, about an hour | <1% | 101 | $9K |
| 81025 | <1% | 1,984 | $9K | |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 257 | $8K |
| 99205 | Prolong outpt/office vis | <1% | 98 | $6K |
| 99407 | <1% | 1,037 | $4K | |
| 90833 | Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) | <1% | 78 | $3K |
| 99401 | <1% | 1,530 | $2K | |
| G2086 | Office-based treatment for opioid use disorder, including development of the treatment plan, care coordination, individual therapy and group therapy and counseling; at least 70 minutes in the first calendar month | <1% | 39 | $2K |
| 99492 | <1% | 60 | $1K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 355 | $555.31 |
| 90853 | Group psychotherapy (other than of a multiple-family group) | <1% | 15 | $281.76 |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | 0% | 12 | $0.00 |
| G0444 | Annual depression screening, 5 to 15 minutes | 0% | 94 | $0.00 |
| 4004F | 0% | 485 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialTURNER, ANDREW (PRESIDENT/COO)
| Provider | Location | Paid |
|---|---|---|
| Impact Healthcare, PLLC | Jackson, TN | $10.11M |
| Impact Behavioral Counseling LLC | Dallas, TX | $255K |
| Impact Healthcare, PLLC | Springfield, TN | $0.00 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.